Expertise in
5
conditions

Jean-pierre P. Routy

Montreal, QC, CA 
Expertise in
5
conditions
Montreal, QC, CA 

Overview

Jean-pierre Routy practices practicing medicine in Montreal, Canada.

Mr. Routy is highly rated in 5 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Kaposi Sarcoma, Lymphofollicular Hyperplasia, Orchiectomy, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 345 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Montreal, QC, Canada
Other Locations
Canada
Toronto, ON, Canada
Quebec, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Proof-of-concept Study to Assess the Effect of Recombinant Human Growth Hormone on the Size of the Replication-competent Viral Reservoir in HIV-infected Individuals on Suppressive Antiretroviral Therapy
A Proof-of-concept Study to Assess the Effect of Recombinant Human Growth Hormone on the Size of the Replication-competent Viral Reservoir in HIV-infected Individuals on Suppressive Antiretroviral Therapy
Enrollment Status: Completed
Publish Date: September 25, 2025
Intervention Type: Drug
Study Drug: Somatotropin
Study Phase: Phase 2
FULL TITLE: Camu Camu Effects on Circulating LPS and Systemic Immune Activation in ART-treated Participants: the Camu Camu Pilot Study
FULL TITLE: Camu Camu Effects on Circulating LPS and Systemic Immune Activation in ART-treated Participants: the Camu Camu Pilot Study
Enrollment Status: Completed
Publish Date: November 20, 2024
Intervention Type: Biological
Study Drug: Camu Camu Capsules
Study Phase: Phase 1
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
A Phase IV, Multicentre Randomized Prospective Open Label Study to Evaluate Whether Switching From Current cART to Triumeq in Addition to Adherence Support Will Enhance Virologic Control and Adherence in Vulnerable Populations Relative to Adherence Support Alone
A Phase IV, Multicentre Randomized Prospective Open Label Study to Evaluate Whether Switching From Current cART to Triumeq in Addition to Adherence Support Will Enhance Virologic Control and Adherence in Vulnerable Populations Relative to Adherence Support Alone
Enrollment Status: Completed
Publish Date: September 03, 2020
Intervention Type: Drug, Behavioral
Study Phase: Phase 4
View 3 Less Clinical Trials

344 Total Publications

Immunometabolic reprogramming via GLP-1 receptor agonists in people with HIV: A multidimensional systemic framework.
Immunometabolic reprogramming via GLP-1 receptor agonists in people with HIV: A multidimensional systemic framework.
Journal: Bioscience trends
Published: August 23, 2026

Frequently Asked Questions about Jean-pierre P. Routy

Is Jean-pierre P. Routy a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-pierre P. Routy is classified as an Elite expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-pierre P. Routy participate in research or clinical trials?

Yes. Jean-pierre P. Routy has published 344 articles and abstracts on conditions like HIV/AIDS. You can view a list of Jean-pierre P. Routy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Routy's expertise for a condition
ConditionClose
    View All 54 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile